GENRX RIZATRIPTAN rizatriptan (as benzoate) 10 mg orally disintegrating tablets blister pack

Active ingredient:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

rizatriptan benzoate

Pharmaceutical form:

Tablet, orally disintegrating

Composition:

Excipient Ingredients: crospovidone; sucralose; microcrystalline cellulose; mannitol; magnesium stearate; Flavour

Administration route:

Oral

Units in package:

2

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Rizatriptan is indicated for the acute treatment of migraine attacks with or without aura.

Product summary:

Visual Identification: White to off-white coloured, round-shaped tablets with "APO" engraved on one side and "RZ" over "10" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Licence status A

Authorization date:

2016-02-09